Tag: 30-month stay

30-Month Stay: How Patent Litigation Delays Generic Drug Approval

The 30-month stay under the Hatch-Waxman Act delays generic drug approval when patent lawsuits are filed. Learn how this legal tool affects drug prices, innovation, and patient access to affordable medications.

Read More